<i>Helicobacter pylori</i> infection has a detrimental impact on the efficacy of cancer immunotherapies
P Oster(University Hospital of Lausanne), Dominique Velin(University Hospital of Lausanne), Corentin Richard(Centre Georges François Leclerc), Caroline Truntzer(Centre Georges François Leclerc), Emeric Limagne(Centre Georges François Leclerc), Erika Riva(University Hospital of Lausanne), Christina Begka(University Hospital of Lausanne), Elisavet Machremi(University Hospital of Lausanne), Grégory Verdeil(University of Lausanne), François Ghiringhelli(Inserm), M.M. Leblond(Centre National de la Recherche Scientifique), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Bertrand Routy(Université Paris-Sud), Brynn McMillan(University Hospital of Lausanne), Laurie Vaillant(University Hospital of Lausanne)
Cited by 169
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
|Journal of Clinical Investigation|2010|985
CD4<b>+</b>CD25<b>+</b> regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
|The Journal of Experimental Medicine|2005|918
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
|Annals of Oncology|2018|863
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639